前往化源商城

Connecticut medicine 2013-09-01

Life-threatening hyperkalemia: a potentially lethal drug combination.

Tristan Juvet, Venkata C Gourineni, Sandeep Ravi, Stuart W Zarich

文献索引:Conn. Med. 77(8) , 491-3, (2013)

全文:HTML全文

摘要

Hyperkalemia is commonly seen in the elderly and is occasionally fatal. Inadvertently combining potassium sparing medications can result in profound hyperkalemia which may result in cardiac dysrhythmias, especially in the setting of chronic kidney disease. An 85 year-old woman on a drug regimen of sotalol, valsartan, spironolactone, and trimethoprim-sulfamethoxazole presented to the emergency department with hypotension and bradycardia. Presumptive treatment for hyperkalemia was started based on her initial electrocardiogram. This diagnosis was later confirmed with a serum potassium value of 10.1 mmol/L. Following pharmacologic treatment, emergency hemodialysis was performed and the patient subsequently recovered. It is known that several drug classes can cause hyperkalemia, with elderly patients at a higher risk of developing this side effect. It is believed that this was a major contributor to the degree of hyperkalemia seen in this patient.

相关化合物

结构式 名称/CAS号 全部文献
螺内酯 结构式 螺内酯
CAS:52-01-7
盐酸索他洛尔 结构式 盐酸索他洛尔
CAS:959-24-0